Source link : https://www.newshealth.biz/health-news/cabozantinib-benefits-advanced-neuroendocrine-tumors/
Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo. Medscape Medical News Source link : https://www.medscape.com/viewarticle/cabozantinib-improves-pfs-advanced-neuroendocrine-tumors-2025a10003s3?src=rss Author : Publish date : 2025-02-13 11:40:54 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2025-02-13 11:40:54
Copyright for syndicated content belongs to the linked Source.